NEW ORLEANS, April 26, 2010 (GLOBE NEWSWIRE) -- Mauna Kea Technologies, Inc., a leader in the in vivo cellular imaging market, announced that Cellvizio probe-based confocal laser endomicroscopy will be featured in key presentations at the annual Digestive Disease Week (DDW) 2010 conference taking place in New Orleans May 1st thru the 5th. DDW is the world's largest gathering of physicians and researchers in the fields of gastroenterology, hepatology, endoscopy and gastrointestinal surgery.
"Data presented at this year's DDW significantly validate Cellvizio as a vital tool to improve early detection of GI and biliary cancers," said Sacha Loiseau, President and Chief Executive Officer of Mauna Kea Technologies. "Clinical evidence continues to show that the cellular-level information that this new imaging tool provides is helping physicians more effectively evaluate their patients conditions and make decisions on which surveillance or treatment option to consider."
Highlights include the results of "DONT BIOPCE study" (Oral Presentation #1071), the large, prospective multi-center, international, randomized, controlled trial designed to evaluate if Cellvizio could improve outcomes and surveillance efficiency in patients with Barrett's esophagus, as well as the findings from the large, multi-center Cellvizio ERCP registry trial (Oral Presentation #788) for the evaluation of indeterminate strictures the bile and pancreatic ducts.
Members of the media are invited to attend the presentations and poster and to meet with company management at booth number 547. To arrange for a physician interview or for further information, contact Erich Sandoval at esandoval@lazarpartners.com.
All data are embargoed until the time of presentation:
| TUESDAY, MAY 4, 2010 |
| Oral Presentation #713: "The Learning Curve of Probe-Based Confocal Laser Endomicroscopy (pCLE) for |
| Detection Neoplasia in Colon Polyps" |
| Presenter: Anna Buchner, M.D., Ph.D., University of Pennsylvania |
| Date: Tuesday, May 4, 2010 |
| Time: 2:30 PM |
| Location: Ernest N. Morial Convention Center, Room 397 |
| Oral Presentation #788: "Miami Classification (MC) of Probe-Based Confocal Laser Endomicroscopy |
| (pCLE) Findings in the Pancreaticobiliary (PB) System for Evaluation of Indeterminate Strictures: Interim |
| Results From an International Multicenter Registry" |
| Presenter: Yang Chen, M.D., University of Colorado |
| Date: Tuesday, May 4, 2010 |
| Time: 2:39 pm |
| Location: Ernest N. Morial Convention Center, Room 280-282 |
| Oral Presentation #717: "Computer-Assisted Diagnosis of Colonic Polyps by Probe-Based Confocal Laser |
| Endomicroscopy" |
| Presenter: Pushpak Taunk, Boston University School of Medicine/Boston VA |
| Date: Tuesday May 4, 2010 |
| Time: 3:30 PM |
| Location: Ernest N. Morial Convention Center, Room 397 |
| Distinguished Oral Presentation #847: "The Role of a High Definition, Probe-Based Confocal Laser |
| Endomicroscopy (pCLE) System in Diagnosing Smaller Indeterminate Colorectal Polyps In Vivo" |
| Presenter: Anna Buchner, M.D. , Ph.D., University of Pennsylvania |
| Date: Tuesday, May 4, 2010 |
| Time: 5:00 PM |
| Location: Ernest N. Morial Convention Center, Room 292 |
| WEDNESDAY, MAY 5, 2010 |
| Oral Presentation #1071: "Detection of Neoplastic Tissue in Barrett's Esophagus With In Vivo Probe- |
| Based Confocal Endomicroscopy (DONT BIOPCE). Final Results of a Prospective International RCT: Image |
| Guided Versus 4 Quadrant Random Biopsies?" |
| Presenter: Prateek Sharma, M.D., University of Kansas Medical Center |
| Date: Wednesday, May 5, 2010 |
| Time: 2:30 PM |
| Location: Ernest N. Morial Convention Center, Room 297 |
| Oral Presentation #1074: "Accuracy and Inter-Observer Variability of in-Vivo Probe-Based Confocal Laser |
| Endomicroscopy Criteria for Dysplastic vs Non Dysplastic Barrett's Esophagus (BE)" |
| Presenter: Jaya Arora, M.D., University of Kansas Medical Center |
| Date: Wednesday, May 5, 2010 |
| Time: 3:15 PM |
| Location Ernest N. Morial Convention Center, Room 297 |
About DDW
DDW is the largest international gathering of physicians, researchers and academics in the fields of gastroenterology, hepatology, endoscopy and gastrointestinal surgery. Jointly sponsored by the American Association for the Study of Liver Diseases, the American Gastroenterological Association (AGA) Institute, the American Society for Gastrointestinal Endoscopy and the Society for Surgery of the Alimentary Tract, DDW takes place May 1 - 5, 2010, at the Ernest N. Morial Convention Center, New Orleans, LA. The meeting showcases approximately 5,000 abstracts and hundreds of lectures on the latest advances in GI research, medicine and technology. For more information, visit www.ddw.org.
About Cellvizio
Cellvizio, the world's smallest and most flexible microscope, is the first system designed to provide real time live images of internal human tissues at the cellular level during endoscopic procedures. This new method, known as probe-based Confocal Laser Endomicroscopy (pCLE), allows physicians to visualize an area of interest and use this information in the overall assessment of the patient's condition, which may aid in real-time treatment decisions. This new, advanced imaging technique helps physicians to detect abnormalities more effectively so patients may be treated earlier and may undergo fewer endoscopic procedures. Physicians and thought leaders at almost 100 top medical institutions around the world have completed over 4,000 of these procedures and have published more than 35 peer-reviewed papers on the technology in major medical journals. Cellvizio, which delivers up to 12 microscopic images per second and can be used with almost any endoscope, has premarket notification 510(k) clearance from the U.S. Food and Drug Administration and the European CE-Mark for use in the GI and pulmonary tracts.
About Mauna Kea Technologies
Mauna Kea Technologies is a medical device company based in Paris, France. With its flagship Cellvizio systems, the company leads the growing endomicroscopy imaging market, enabling physicians to visualize, diagnose and treat directly inside the body in real time, pathologies that may not be seen using other imaging techniques. Investors include Psilos Group, Seventure and Creadev. For more information about Mauna Kea Technologies visit www.maunakeatech.com.